BNTC

NASDAQ · Biotechnology

Benitec Biopharma Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.54

+0.90 (+10.42%)

As of Nov 7, 2:06 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +181.7% upside

Low Target $21.20

Average Target $26.87

High Target $38.04

Current Price $9.54

Current
$9.54

Target
$26.87

$21.20 $26.87 avg $38.04

Scenario Analysis

Bear Case

$21.20

122.2%

Low target

Base Case

$26.87

+181.7%

Avg target

Bull Case

$38.04

+298.7%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$15.86

-39.8% from high

52-Week Low

$7.89

+21.0% from low

Target vs 52W High

$26.87

+69.4% vs high

Next Earnings Report

Nov 12, 2026

until earnings

EPS Est: $-0.29

Earnings in 4 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%